Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00836251 · ClinicalTrials.gov registry record
Effects of Antipsychotic Medications on Energy Intake and Expenditure
A clinical trial of Schizophrenia and Schizoaffective Disorder, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00836251: Completed study of Schizophrenia and Schizoaffective Disorder, sponsored by Washington University School of Medicine.
NCT00836251 is a study of Schizophrenia and Schizoaffective Disorder that has completed, run by Washington University School of Medicine. The registered enrollment target is 15 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00836251, a study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: To evaluate the effect of antipsychotic treatment group on Activity Energy Expenditure. The project hypothesizes that subjects treated with olanzapine will demonstrate a greater decrease in AEE over time than subjects treated with ziprasidone, due at least in part to sedating effects of olanzapine. Aim 2: To evaluate the effect of antipsychotic treatment group on Energy Intake. The project hypothesizes that subjects treated with olanzapine will demonstrate a greater increase in EI over time than subjects treated with ziprasidone, based on higher histamine type 1 (H1) receptor affinity of olanzapine and the relationship between H1 affinity and hunger and/or satiety.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT H218O and 2H2O, administered as a mixed cocktail
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-06 |
What the finished NCT00836251 record still lists
NCT00836251 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which H218O and 2H2O, administered as a mixed cocktail is the first listed.
NCT00836251 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00836251 about?
NCT00836251 is a clinical study titled "Effects of Antipsychotic Medications on Energy Intake and Expenditure". Aim 1: To evaluate the effect of antipsychotic treatment group on Activity Energy Expenditure. The project hypothesizes that subjects treated with olanzapine will demonstrate a greater decrease in AEE over time than subjects treated with ziprasidone, due at least in part to sedating effects of olanz...
What is the current status of trial NCT00836251?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2006-04. Estimated completion is 2008-06.
What conditions does trial NCT00836251 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder, Weight Gain.
What interventions are being tested in trial NCT00836251?
The interventions under investigation include: H218O and 2H2O, administered as a mixed cocktail (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00836251?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00836251 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00836251's enrollment target sits among peer trials
15 301st of 315 higher than 13 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Tolerability of MDMA in Schizophrenia
RECRUITING · Phase 1
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia